These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 34117180)
1. Assessing the Efficacy and Safety of Tirofiban in Combination With Dual-antiplatelet Therapy in Progressive Ischemic Stroke Patients. Zhang H; Lin F; Zhao Y; Chang W; Liu H; Yin J; Li L J Cardiovasc Pharmacol; 2021 Sep; 78(3):448-452. PubMed ID: 34117180 [TBL] [Abstract][Full Text] [Related]
2. Effects of Oral Antiplatelet Agents and Tirofiban on Functional Outcomes of Patients with Non-Disabling Minor Acute Ischemic Stroke. Wang H; Li X; Liu C; Huang S; Liang C; Zhang M J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104829. PubMed ID: 32689578 [TBL] [Abstract][Full Text] [Related]
3. Time to treatment and disability attributed to index stroke in the POINT trial. Balali P; Easton JD; Johnston SC; Cucchiara B J Stroke Cerebrovasc Dis; 2024 Nov; 33(11):107988. PubMed ID: 39222701 [TBL] [Abstract][Full Text] [Related]
4. Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial. Hoshino H; Toyoda K; Omae K; Ishida N; Uchiyama S; Kimura K; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T; Stroke; 2021 Nov; 52(11):3430-3439. PubMed ID: 34404237 [TBL] [Abstract][Full Text] [Related]
5. Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial. Chen HS; Cui Y; Zhou ZH; Zhang H; Wang LX; Wang WZ; Shen LY; Guo LY; Wang EQ; Wang RX; Han J; Dong YL; Li J; Lin YZ; Yang QC; Zhang L; Li JY; Wang J; Xia L; Ma GB; Lu J; Jiang CH; Huang SM; Wan LS; Piao XY; Li Z; Li YS; Yang KH; Wang DL; Nguyen TN; JAMA; 2023 Jun; 329(24):2135-2144. PubMed ID: 37367978 [TBL] [Abstract][Full Text] [Related]
6. Risk of Early Bleeding with Dual Antiplatelet Therapy in Acute Stroke and Transient Ischemic Attack Regardless of NIHSS Admission. Scavasine VC; Barbosa RM; Lopes Neto FDN; Germininani FMB; Bazan R; Zétola VF; Massaro AR; Lange MC J Stroke Cerebrovasc Dis; 2021 May; 30(5):105677. PubMed ID: 33677312 [TBL] [Abstract][Full Text] [Related]
7. Treatment Strategies and Prognosis for Moderate Stroke Patients in China. Wang L; Zhou Q; Gu H; Hao M; Xiong Y; Wang Y Cerebrovasc Dis; 2024; 53(5):547-555. PubMed ID: 37980890 [TBL] [Abstract][Full Text] [Related]
8. Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort. Ornello R; Foschi M; De Santis F; Romoli M; Tassinari T; Saia V; Cenciarelli S; Bedetti C; Padiglioni C; Censori B; Puglisi V; Vinciguerra L; Guarino M; Barone V; Zedde M; Grisendi I; Diomedi M; Bagnato MR; Petruzzellis M; Mezzapesa DM; Di Viesti P; Inchingolo V; Cappellari M; Zivelonghi C; Candelaresi P; Andreone V; Rinaldi G; Bavaro A; Cavallini A; Moraru S; Querzani P; Terruso V; Mannino M; Pezzini A; Frisullo G; Muscia F; Paciaroni M; Mosconi MG; Zini A; Leone R; Palmieri C; Cupini LM; Marcon M; Tassi R; Sanzaro E; Paci C; Viticchi G; Orsucci D; Falcou A; Beretta S; Tarletti R; Nencini P; Rota E; Sepe FN; Ferrandi D; Caputi L; Volpi G; La Spada S; Beccia M; Rinaldi C; Mastrangelo V; Di Blasio F; Invernizzi P; Pelliccioni G; De Angelis MV; Bonanni L; Ruzza G; Caggia EA; Russo M; Tonon A; Acciarri MC; Anticoli S; Roberti C; Manobianca G; Scaglione G; Pistoia F; Fortini A; De Boni A; Sanna A; Chiti A; Barbarini L; Caggiula M; Masato M; Del Sette M; Passarelli F; Bongioanni MR; Toni D; Ricci S; De Matteis E; Sacco S; J Am Heart Assoc; 2024 Aug; 13(16):e036275. PubMed ID: 39119964 [TBL] [Abstract][Full Text] [Related]
9. Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Mild-to-Moderate Acute Ischemic Stroke According to the Risk of Recurrent Stroke: An Analysis of 15 000 Patients From a Nationwide, Multicenter Registry. Lee HL; Kim JT; Lee JS; Park MS; Choi KH; Cho KH; Kim BJ; Park JM; Kang K; Lee SJ; Kim JG; Cha JK; Kim DH; Park TH; Park SS; Lee KB; Lee J; Hong KS; Cho YJ; Park HK; Lee BC; Yu KH; Sun Oh M; Kim DE; Ryu WS; Choi JC; Kwon JH; Kim WJ; Shin DI; Sohn SI; Hong JH; Lee J; Bae HJ Circ Cardiovasc Qual Outcomes; 2020 Nov; 13(11):e006474. PubMed ID: 33201737 [TBL] [Abstract][Full Text] [Related]
10. Contemporary Prestroke Dual Antiplatelet Use and Symptomatic Intracerebral Hemorrhage Risk After Thrombolysis. Peng TJ; Schwamm LH; Fonarow GC; Hassan AE; Hill M; Messé SR; Coronado F; Falcone GJ; Sharma R JAMA Neurol; 2024 Jul; 81(7):722-731. PubMed ID: 38767894 [TBL] [Abstract][Full Text] [Related]
11. Dual antiplatelet therapy after intravenous thrombolysis for patients with minor ischemic stroke:A meta-analysis. Zeng J; Xin W; Tang S; Xiang C; Zeng C Clin Neurol Neurosurg; 2024 Mar; 238():108176. PubMed ID: 38417246 [TBL] [Abstract][Full Text] [Related]
12. Early dual antiplatelet therapy in patients with minor ischemic stroke after intravenous thrombolysis. Alet MJ; Balcarce P; Ameriso SF J Stroke Cerebrovasc Dis; 2024 Oct; 33(10):107903. PubMed ID: 39084339 [TBL] [Abstract][Full Text] [Related]
13. Dual antiplatelet therapy versus intravenous tissue plasminogen activator with acute minor ischemic stroke: A systematic review and meta-analysis of safety and efficacy. Abbas A; Hamad AA; El Din Moawad MH; Ewis DK; Youssef RA; Hamouda H; Hassan MA; Aladawi M; Elfil M; Meshref M; Al-Mufti F J Stroke Cerebrovasc Dis; 2024 Jul; 33(7):107704. PubMed ID: 38561167 [TBL] [Abstract][Full Text] [Related]
14. Association between tirofiban monotherapy and efficacy and safety in acute ischemic stroke. Tao C; Zhu Y; Zhang C; Song J; Liu T; Yuan X; Luo W; Chen C; Liu D; Zhu Y; Liu J; Hu W BMC Neurol; 2021 Jun; 21(1):237. PubMed ID: 34167477 [TBL] [Abstract][Full Text] [Related]
15. Effect of alteplase versus aspirin plus clopidogrel in acute minor stroke. Lan L; Rong X; Shen Q; Gong H; Li X; Wang H; Li M; Pan J; Zhang X; Peng Y Int J Neurosci; 2020 Sep; 130(9):857-864. PubMed ID: 31928267 [No Abstract] [Full Text] [Related]
16. Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke (ATAMIS): a parallel, randomised, open-label, multicentre, prospective study. Hou X; Li X; Wang X; Chen H Stroke Vasc Neurol; 2018 Dec; 3(4):263-267. PubMed ID: 30637134 [TBL] [Abstract][Full Text] [Related]
17. Dual Antiplatelet Therapy and Outcomes in Acute Mild to Moderate Stroke With Versus Without Large-Artery Atherosclerosis Post Hoc Analysis of ATAMIS. Cui Y; Liu QY; Chen HS J Am Heart Assoc; 2024 Sep; 13(18):e036318. PubMed ID: 39248249 [TBL] [Abstract][Full Text] [Related]
18. Effect of tirofiban in treating patients with progressive ischemic stroke. Du N; Wang LX; Liu YL; Yin XL; Zhao JS; Yang L Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):2098-2105. PubMed ID: 35363359 [TBL] [Abstract][Full Text] [Related]
19. Intravenous tirofiban therapy for patients with capsular warning syndrome. Li W; Wu Y; Li XS; Liu CC; Huang SH; Liang CR; Wang H; Zhang LL; Xu ZQ; Wang YJ; Zhang M Stroke Vasc Neurol; 2019 Mar; 4(1):22-27. PubMed ID: 31105975 [TBL] [Abstract][Full Text] [Related]
20. Safety of tirofiban and dual antiplatelet therapy in treating intracranial aneurysms. Samaniego EA; Gibson E; Nakagawa D; Ortega-Gutierrez S; Zanaty M; Roa JA; Jabbour P; Hasan DM Stroke Vasc Neurol; 2019 Mar; 4(1):36-42. PubMed ID: 31105977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]